From 2008, Professor of General Pathology at the Department of Biomolecular Sciences (DISB) of the University of Urbino Carlo Bo (Italy).
Member of the European TRANSAUTOPHAGY Cost Action.
Training: Dentistry, Biomedical Research, Bioengineering, Pathology
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and molecular mechanism.
Positions: Past-President, NAALT; President-Elect WALT, Co-Chair SPIE, Chair, ASLMS
Interests: Signal Transduction, Lasers, Biological regulation, Photobiomodulation.
Dr. Mehmet Burak ATEŞ is a researcher supporting the integration of innovative educational technology for clinical teaching and learning in veterinary health sciences.
His special interests are veterinary pathology, experimental pathology, toxicopathology, molecular pathology, molecular oncology, liver and brain pathology.
Dr. Ateş's portfolio includes a wide range of scientific articles in peer-reviewed journals, books, and conference proceedings published.
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Dr. Anissa Daliry is a biologist at the Federal College of Pernambuco (UFPE) and holds a master's degree and a PhD in cellular and molecular biology from FIOCRUZ and a postdoctoral degree from Biophysics/UFRJ. Dr. Anissa is a permanent professor of Cell and Molecular Biology program, IOC/FIOCRUZ (level 7/ CAPES) and young scientist of our state/FAPERJ (2021-2024). Her main research focus is to study molecular, physiological pathways and mechanisms involved in the development of cardiovascular and metabolic diseases such as obesity, metabolic syndrome, diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD) and Chagas disease. She performs pre-clinical and clinical studies. She coordinates the postgraduate course "Cardiovascular and Metabolic Diseases: from bench to the bedside." She is a reviewer for 13 indexed international journals. Since 2020, she has collaborated in the Longitudinal Study of Brazilian Health, ELSA-BRASIL. She is also a member of the Liver Center and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFte). She develops projects in technological innovation with the development of a medical device for the quantification of hepatic steatosis. Dr. Anissa is a member of the research directory group entitled: Longitudinal Study of Adult Health - RJ/Fiocruz Research Center, coordinated by Dr. Rosane Griep/IOC and leader of the CNPq research group entitled: Study group on pathophysiology and therapy of chronic non-communicable and infectious diseases.
Associate Professor at Dental Research Center, Tehran University of Medical Sciences.
DDS, MS, Observer at the Armed Forces Institute of Pathology (AFIP), Washington D.C.
Associate Editor/Editorial Board: Frontiers in Dentistry, BMC Cancer.
Research Interests: Oral and Maxillofacial Pathology, Angiogenesis, Odontogenic Benign and Malignant Lesions, Cellular and Molecular interactions in Cancer
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
Dr. Carlos Eurico Fernandes is Professor within the Experimental Pathology Laboratory at the Institute of Biosciences, Federal University of Mato Grosso do Sul, Brazil.
His research within the Experimental Pathology Laboratory focuses on descriptive and functional histology, with an emphasis on biometric, histological, histopathological and histomorphometric analyses, having fish and anurans as experimental models.
Dr. Liang Gao currently works as a senior Research Fellow at the Center of Experimental Orthopaedics, Saarland University, Germany. His clinical interests include sports medicine, arthroplasty, and traumatology. His research focuses on joint preservation and orthobiologics.
Dr. Gao studied Medicine in China and Germany with intensive fellowship training in both Asia and Europe. He completed the Musculoskeletal Surgical Oncology residency training at Peking University Medical Center, China. Moreover, he obtained his master of science degree (Radiation Oncology) from Heidelberg University, Germany and his doctorate (Biological Therapy) summa cum laude from Saarland University, Germany.
Dr. Gao is the Member of the Basic Science Committee of International Cartilage Regeneration & Joint Preservation Society (ICRS), the Member of the Early Career Investigator Committee of Osteoarthritis Research Society International (OARSI), and the Founding Member of the Sino Euro Orthopaedics Society (SEOS).
Education: D.V.M., Ph.D., Veterinary Faculty Zagreb, field of pathological anatomy. Professor of the Department of General Pathology and Pathological Morphology at the Veterinary Faculty Zagreb.
Summary of research activity: Experimental gastrointestinal diseases especially inflammatory bowel disease and ulcer disease; neoplastic diseases of the dogs and cats with comparative tumor pathology; monitoring of the new diseases emerging in Croatia.
Memberships and awards: European Society of Veterinary Pathology, European Society of Veterinary Clinical Pathology, New York Academy of Sciences, Croatian Veterinary Association, Award for the contribution to the field of comparative pathology Prof. dr. Ljudevit Jurak.
Publications: main editor of the official journal of the Croatian Veterinary Association –Croatian Veterinary Record; more than 300 publications among which more than 90 are published in the SCI indexed journals; five books and textbooks in the field of pathological anatomy.
Dr. He obtained her Ph.D. degree from a joint Ph.D. program in Jilin University and University of California, San Diego under Prof. Shu Chien which is the Academician of National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and American Academy of Arts and Sciences of US. Dr. He then worked in Los Alamos National Laboratory (LANL) in the United States, Chinese Academy of Sciences and Shanghai Jiao Tong University in China. In 2019, Dr. He joined the Center for Single-Cell Omics in Shanghai Jiao Tong University School of Medicine as the core director of the genomics core.
Dr. He’s research focused on developing more sophisticated technology of single-cell multiple-omics analysis, using systems biology strategies to elucidate the underlying mechanism of major diseases, especially oncology and discover novel biomarkers, and AI Drug Screening. As of June. 2022, Dr. He has authored 60 high-quality scholarly articles including 25 first-authored and correspondence author papers, which have been extensively cited. Also, Dr. He has filed 15 patents. Also, she has been awarded research grants and awards from National Natural Science Foundation, China Postdoctoral Science Special Foundation, and so on. Dr. He was invited to contribute review articles by highly influential research journals in her field and give oral presentations at national and international conferences. Dr. He also serves as an article reviewer of numerous notable international journals.
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.